Fundraising Fox

KiraGen Bio

3 known investors

kiragenbio.com ↗

KiraGen Bio develops gene-edited, donor-derived cell therapies designed to resist tumor microenvironment suppression and maintain durable function. Its platform focuses on combining multiple gene edits to produce scalable, allogeneic cell therapy candidates.

BiotechDeep TechHealthtech

Investors · 3

2048 VenturesNew York · $500K – $3M
Fifty YearsSan Francisco · $250K – $2M
ZAKA VCSan Francisco

In the news

KiraGen Bio Secures $1.4M | SignalBasetrysignalbase.com · Mar 2026KiraGen Bio Welcomes Investment from the Yuvaan Tiwari Foundationkiragenbio.com · Jan 2026KiraGen Bio Selected for Recode Edge ’25 Cohort, in the Running for $2M in Follow-On Investmentkiragenbio.com · Apr 2025Top 10 Oncology Capital Raises in the U.S. - October 1st-15th, 2024castleplacement.com · Oct 2024

Frequently asked questions

What does KiraGen Bio do?
KiraGen Bio develops gene-edited, donor-derived cell therapies designed to resist tumor microenvironment suppression and maintain durable function. Its platform focuses on combining multiple gene edits to produce scalable, allogeneic cell therapy candidates.
Who are KiraGen Bio's investors?
KiraGen Bio's investors include 2048 Ventures, Fifty Years, ZAKA VC.